RSV is the most common reason why babies end up in the hospital in their first year. A new study finds a vaccine for expectant mothers is more effective at protecting babies than previously shown.

A UK Health Security Agency followed 300,000 babies born in England that found 4,500 of them were admitted to hospital - the ...

Explore the latest advances in RSV vaccine research, and what these developments mean for prevention and public health.

A study confirms the vaccine gives excellent protection for babies against life-threatening chest infections.

Malachi was not expected to live beyond 10 years old after contracting RSV as a baby "If my life was a vase, it was like somebody dropped it and all the pieces went everywhere." Those are the words of ...

The CDC reports a highly mutated Cicada COVID variant BA 3.2 has been detected in at least 25 states including New Jersey in what could result in a summer surge of new COVID-19 cases, colliding with ...

A VACCINE given during pregnancy is significantly reducing hospital admissions among newborns due to Respiratory Syncytial ...

A UK study finds the RSV vaccine in pregnancy can reduce infant hospitalisation risk by up to 85%, especially when given in ...

European Commission Approves Merck’s Enflonsia receives European approval for RSV lower respiratory tract disease in infants during their first RSV season: Rahway, New Jersey Mo ...

ENFLONSIA is the first and only RSV preventive option in the European Union for administration to infants without the need for weight-based dosingRAHWAY, N.J.--(BUSINESS WIRE)--$MRK #MRK--Merck (NYSE: ...